% Expired Patents = 71.4

Forward Citations = 116

Loading Chart...

5 inventors (with patents filed for the assignee):

Maria Antonia Buil Albero (6 out of 23 patents)

Maria Dolors Fernandez Forner (5 out of 20 patents)

Maria Prat Quiñones (5 out of 13 patents)

4. Maria Prat Quinones (2 out of 22 patents)

5. Dolors Fernandez Forner (2 out of 5 patents)

7 patents: Sort by Forward Citations

1. 7312231 - Quinuclidine carbamate derivatives and their use as M3 antagonists (2007-12-25),

2. 7208501 - Quinuclidine carbamate derivatives and their use as M3 antagonists (2007-04-24),

3. 7196098 - Quinuclidine derivatives and medicinal compositions containing the same (2007-03-27),

4. 7192978 - Pyrrolidinium derivatives (2007-03-20),

5. 7122558 - Quinuclidine derivatives and medicinal compositions containing the same (2006-10-17),

6. 7109210 - Quinuclidine derivatives and medicinal compositions containing the same (2006-09-19),

7. 7078412 - Quinuclidine derivatives and medicinal compositions containing the same (2006-07-18),

Company Overview

Almirall Prodesfarma Ag is a pharmaceutical company focused on research, development, manufacturing, and commercialization of innovative products in dermatology. With a strong presence in Europe and Latin America, the company is committed to improving the lives of patients by providing high-quality healthcare solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#87 in

#1,340 in Switzerland

CH

Almirall Prodesfarma Ag

Forward Citations = 116

5 inventors:

Maria Antonia Buil Albero (6 out of 23 patents)

Maria Dolors Fernandez Forner (5 out of 20 patents)

Maria Prat Quiñones (5 out of 13 patents)

4. Maria Prat Quinones (2 out of 22 patents)

5. Dolors Fernandez Forner (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Almirall Prodesfarma Ag. Retrieved from https://idiyas.com/company/almirall-prodesfarma-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]